Process Research and Development, Chemical and Analytical Development, Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936, USA
Abstract:
A new reaction of N-aryl-2-pyrimidinamines with triphosgene to afford N-aryl-N-(2-pyrimidinyl)-2-pyrimidinamine is described.